KidsMD Health Topics

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
Condition & Treatments
Search for a Condition or Treatment:
View allSearch
Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Contact the Brain Tumor Center

Germinoma in Children

  • Overview

    At Dana-Farber/Children’s Hospital Cancer Center, we have already helped many infants, children and adolescents who have been diagnosed with a germinoma: a specific type of germ cell tumor that is usually malignant (cancerous). These tumors, which originate from sex cells, become “trapped” in the brain during utero instead of migrating down toward the testes or ovaries.

    Here is some basic information about germinomas:

    • Germinomas are sensitive to chemotherapy and radiation therapy and both can be used to help achieve an excellent cure rate. 
    • The prognosis and treatment of each of these depends on their location, size, and other characteristics.
    • Most germ cell tumors are found in the ovaries or testes. When found in the brain, they’re known as “intracranial germ cell tumors.”

    Learn more detailed information about germ cell tumors of the brain and germ cell tumors of the ovaries.

    How Dana-Farber/Children’s Hospital Cancer Center approaches germ cell tumors of the brain

    At the Dana-Farber/Children’s Hospital Cancer Center, we hold a weekly brain tumor clinic for newly diagnosed children currently receiving treatment. At each appointment, you meet with specialists on your child’s team, from our pediatric neuro-oncologist, neurologist and neurosurgeon, to our pediatric endocrinologist, psycho-oncologist and School liaison.

    Dana-Farber/Children’s Hospital Cancer Center’s Pediatric Brain Tumor Program offers the following services:

    • Access to high-tech resources, like the intra-operative MRI, which allows our pediatric neurosurgeons to visualize the tumor as they operate with MRI scans. This means they can remove as much of the tumor as possible, and sometimes eliminate additional surgeries.
    • Expert neuropathological review, using advanced molecular diagnostic testing, to identify your child’s exact type of tumor. This information helps predict which treatments are more likely to work.
    • Access to unique Phase I clinical trials, from our own investigators, the Children’s Oncology Group and the Pediatric Oncology Experimental Therapeutics Investigators Consortium. Studies offer treatment options beyond standard therapy.
    • Ongoing care from pediatric neurologists familiar with the early symptoms and side effects of brain tumors and their treatments.
    • Access to one of the nation’s few dedicated pediatric brain tumor survivorship programs. This weekly clinic offers ongoing care to manage late effects caused by your child’s tumor or the treatment they received.

    Germinoma: Reviewed by Peter E. Manley, MD
    © Children’s Hospital Boston; posted in 2012

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO